157 related articles for article (PubMed ID: 35934991)
21. Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review.
Ramachandran AK; Das S; Joseph A
Curr Neuropharmacol; 2021; 19(10):1688-1700. PubMed ID: 33441073
[TBL] [Abstract][Full Text] [Related]
22. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
23. Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19).
Baig AM; Sanders EC
J Med Virol; 2020 Oct; 92(10):1845-1857. PubMed ID: 32492193
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
Gheblawi M; Wang K; Viveiros A; Nguyen Q; Zhong JC; Turner AJ; Raizada MK; Grant MB; Oudit GY
Circ Res; 2020 May; 126(10):1456-1474. PubMed ID: 32264791
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
27. Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2).
To KF; Lo AW
J Pathol; 2004 Jul; 203(3):740-3. PubMed ID: 15221932
[TBL] [Abstract][Full Text] [Related]
28. Neurological manifestations of COVID-19: available evidences and a new paradigm.
Khatoon F; Prasad K; Kumar V
J Neurovirol; 2020 Oct; 26(5):619-630. PubMed ID: 32839951
[TBL] [Abstract][Full Text] [Related]
29. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 Infection of Human Neurons Is TMPRSS2 Independent, Requires Endosomal Cell Entry, and Can Be Blocked by Inhibitors of Host Phosphoinositol-5 Kinase.
Kettunen P; Lesnikova A; Räsänen N; Ojha R; Palmunen L; Laakso M; Lehtonen Š; Kuusisto J; Pietiläinen O; Saber SH; Joensuu M; Vapalahti OP; Koistinaho J; Rolova T; Balistreri G
J Virol; 2023 Apr; 97(4):e0014423. PubMed ID: 37039676
[TBL] [Abstract][Full Text] [Related]
31. Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain.
Zhao Y; Li W; Lukiw W
Folia Neuropathol; 2021; 59(3):232-238. PubMed ID: 34628788
[TBL] [Abstract][Full Text] [Related]
32. Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications.
Prasada Kabekkodu S; Chakrabarty S; Jayaram P; Mallya S; Thangaraj K; Singh KK; Satyamoorthy K
Mitochondrion; 2023 Mar; 69():43-56. PubMed ID: 36690315
[TBL] [Abstract][Full Text] [Related]
33. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
34. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.
Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK
Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437
[TBL] [Abstract][Full Text] [Related]
36. Application of System Biology to Explore the Association of Neprilysin, Angiotensin-Converting Enzyme 2 (ACE2), and Carbonic Anhydrase (CA) in Pathogenesis of SARS-CoV-2.
Zolfaghari Emameh R; Falak R; Bahreini E
Biol Proced Online; 2020; 22():11. PubMed ID: 32572334
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 and neurological symptoms: is the SARS-CoV-2 virus neurotropic?
Hess DC; Rutkowski E; Morgan J; McCluskey L
Cond Med; 2020 Oct; 3(5):241-245. PubMed ID: 34136764
[TBL] [Abstract][Full Text] [Related]
38. TGF-β1 Inhibition of ACE2 Mediated by miRNA Uncovers Novel Mechanism of SARS-CoV-2 Pathogenesis.
Hejenkowska ED; Mitash N; Donovan JE; Chandra A; Bertrand C; De Santi C; Greene CM; Mu F; Swiatecka-Urban A
J Innate Immun; 2023; 15(1):629-646. PubMed ID: 37579743
[TBL] [Abstract][Full Text] [Related]
39. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
Nicolau LAD; Magalhães PJC; Vale ML
Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
[TBL] [Abstract][Full Text] [Related]
40. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
Achar A; Ghosh C
Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
